Vanguard Investments Australia
VCYT icon

Vanguard Investments Australia’s Veracyte VCYT Stock Holding History

Vanguard Investments Australia’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Hold
19,568
– – ﹤0.01% 1200
2026
Q1 		$630K Buy
+19,568
New +$724K ﹤0.01% 1472

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Investments Australia's VCYT Position: Q2 2026 in Review

Vanguard Investments Australia held its Veracyte (VCYT) position steady in Q2 2026 at 19,568 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1200.

Vanguard Investments Australia first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 369 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Vanguard Investments Australia held 19,568 shares of Veracyte worth $1.15M as of Q2 2026.
  • Vanguard Investments Australia left its Veracyte share count unchanged in Q2 2026.
  • Veracyte made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1200 holding.
  • Vanguard Investments Australia first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
  • 369 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.